Infant Formula
Evaluating the Safety of New Ingredients
Seiten
2004
National Academies Press (Verlag)
978-0-309-09150-3 (ISBN)
National Academies Press (Verlag)
978-0-309-09150-3 (ISBN)
Infant formulas are unique because they are the only source of nutrition for many infants during the first 4 to 6 months of life. This book, prepared at the request of the Food and Drug Administration and Health Canada, addresses the regulatory and research issues that are critical in assessing the safety of the addition of ingredients to infants.
Infant formulas are unique because they are the only source of nutrition for many infants during the first 4 to 6 months of life. They are critical to infant health since they must safely support growth and development during a period when the consequences on inadequate nutrition are most severe. Existing guidelines and regulations for evaluating the safety of conventional food ingredients (e.g., vitamins and minerals) added to infant formulas have worked well in the past; however they are not sufficient to address the diversity of potential new ingredients proposed by manufacturers to develop formulas that mimic the perceived and potential benefits of human milk. This book, prepared at the request of the Food and Drug Administration (FDA) and Health Canada, addresses the regulatory and research issues that are critical in assessing the safety of the addition of new ingredients to infants.
Infant formulas are unique because they are the only source of nutrition for many infants during the first 4 to 6 months of life. They are critical to infant health since they must safely support growth and development during a period when the consequences on inadequate nutrition are most severe. Existing guidelines and regulations for evaluating the safety of conventional food ingredients (e.g., vitamins and minerals) added to infant formulas have worked well in the past; however they are not sufficient to address the diversity of potential new ingredients proposed by manufacturers to develop formulas that mimic the perceived and potential benefits of human milk. This book, prepared at the request of the Food and Drug Administration (FDA) and Health Canada, addresses the regulatory and research issues that are critical in assessing the safety of the addition of new ingredients to infants.
Committee on the Evaluation of the Addition of Ingredients New to Infant Formula
1 Front Matter; 2 Executive Summary; 3 1 Introduction and Background; 4 2 Defining Safety for Infants; 5 3 Comparing Infant Formulas with Human Milk; 6 4 Strengthening the Current Processes to Evaluate New Ingredients for Infant Formulas; 7 5 Testing Ingredients with Preclinical Studies; 8 6 Going Beyond Current Clinical Studies; 9 7 Selecting an In-Market Surveillance Plan; 10 A Acronyms and Glossary; 11 B Composition of Infant Formulas and Human Milk for Feeding Term Infants in the United States; 12 C Redbook Table of Contents; 13 D Applying the Recommended Approaches; 14 E Biographical Sketches of Committee Members
| Erscheint lt. Verlag | 10.7.2004 |
|---|---|
| Zusatzinfo | Illustrations |
| Verlagsort | Washington |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 476 g |
| Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe ► Diätassistenz / Ernährungsberatung |
| Technik ► Lebensmitteltechnologie | |
| ISBN-10 | 0-309-09150-0 / 0309091500 |
| ISBN-13 | 978-0-309-09150-3 / 9780309091503 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Indikation, Diagnostik, Therapie
Buch (2024)
Thieme (Verlag)
CHF 109,95
Physiologische Grundlagen, Prävention, Therapie
Buch | Hardcover (2023)
Wissenschaftliche Verlagsgesellschaft
CHF 165,20
